ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
1-Year Return
24.45%
This Quarter Return
+6.42%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$4.21B
AUM Growth
+$290M
(+7.4%)
Cap. Flow
+$44.3M
Cap. Flow
% of AUM
1.05%
Top 10 Holdings %
Top 10 Hldgs %
19.84%
Holding
1,462
New
252
Increased
614
Reduced
435
Closed
141
Top Buys
| 1 |
NVIDIA
NVDA
|
+$37.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$30.2M |
| 3 |
Verizon
VZ
|
+$29.5M |
| 4 |
Microsoft
MSFT
|
+$21.8M |
| 5 |
Gilead Sciences
GILD
|
+$19.8M |
Top Sells
| 1 |
Tesla
TSLA
|
+$19.4M |
| 2 |
AbbVie
ABBV
|
+$19.1M |
| 3 |
Johnson & Johnson
JNJ
|
+$17.8M |
| 4 |
ServiceNow
NOW
|
+$15.8M |
| 5 |
Roblox
RBLX
|
+$13.4M |
Sector Composition
| 1 | Technology | 21.58% |
| 2 | Energy | 13.05% |
| 3 | Healthcare | 8.58% |
| 4 | Financials | 8.4% |
| 5 | Communication Services | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Schrodinger
SDGR
$1.34B
| $156K | ﹤0.01% |
8,432
-8
| -0.1% | -$148 |
|
1052
Genelux
GNLX
$138M
| $156K | ﹤0.01% |
65,930
+31,047
| +89% | +$73.6K |
|
1053
Ball Corp
BALL
$13.6B
| $156K | ﹤0.01% |
+2,294
| New | +$156K |
|
1054
PPG Industries
PPG
$24.6B
| $154K | ﹤0.01% |
1,160
+707
| +156% | +$93.6K |
|
1055
Genmab
GMAB
$17.1B
| $154K | ﹤0.01% |
6,300
-874
| -12% | -$21.3K |
|
1056
Nuvalent
NUVL
$5.66B
| $153K | ﹤0.01% |
1,493
-1,077
| -42% | -$110K |
|
1057
Janux Therapeutics
JANX
$1.46B
| $153K | ﹤0.01% |
3,357
-2,397
| -42% | -$109K |
|
|
AUTL
1058
Autolus Therapeutics
AUTL
$367M
| $152K | ﹤0.01% |
41,866
+3,740
| +10% | +$13.6K |
|
|
BCYC
1059
Bicycle Therapeutics
BCYC
$485M
| $152K | ﹤0.01% |
6,707
-2,767
| -29% | -$62.6K |
|
1060
Arcus Biosciences
RCUS
$1.25B
| $152K | ﹤0.01% |
9,909
-1,954
| -16% | -$29.9K |
|
|
AGEN
1061
Agenus
AGEN
$154M
| $151K | ﹤0.01% |
27,543
+9,422
| +52% | +$51.6K |
|
1062
Tanger
SKT
$3.86B
| $151K | ﹤0.01% |
+4,548
| New | +$151K |
|
|
SWTX
1063
DELISTED
SpringWorks Therapeutics
SWTX
| $151K | ﹤0.01% |
4,709
+317
| +7% | +$10.2K |
|
1064
Steris
STE
$24B
| $150K | ﹤0.01% |
+619
| New | +$150K |
|
1065
Immatics
IMTX
$706M
| $150K | ﹤0.01% |
13,155
-4,956
| -27% | -$56.5K |
|
1066
Aura Biosciences
AURA
$400M
| $150K | ﹤0.01% |
16,797
-12,334
| -42% | -$110K |
|
1067
Boston Properties
BXP
$11.7B
| $149K | ﹤0.01% |
1,846
+1,730
| +1,491% | +$139K |
|
1068
Fate Therapeutics
FATE
$115M
| $148K | ﹤0.01% |
42,289
+12,230
| +41% | +$42.8K |
|
1069
Nurix Therapeutics
NRIX
$684M
| $148K | ﹤0.01% |
6,583
-8,897
| -57% | -$200K |
|
1070
Relay Therapeutics
RLAY
$700M
| $146K | ﹤0.01% |
20,649
-5,951
| -22% | -$42.1K |
|
1071
Otis Worldwide
OTIS
$34.4B
| $145K | ﹤0.01% |
1,398
+1,281
| +1,095% | +$133K |
|
1072
Immuneering
IMRX
$338M
| $145K | ﹤0.01% |
58,349
-16,590
| -22% | -$41.3K |
|
1073
State Street
STT
$31.4B
| $144K | ﹤0.01% |
1,633
+1,560
| +2,137% | +$138K |
|
1074
Norfolk Southern
NSC
$61.1B
| $144K | ﹤0.01% |
+580
| New | +$144K |
|
1075
IDEAYA Biosciences
IDYA
$2.17B
| $144K | ﹤0.01% |
4,547
-304
| -6% | -$9.63K |
|